Sildenafil Citrate (VIAGRA(R)) Improves Erectile Function in Elderly Patients With Erectile Dysfunction: A Subgroup Analysis
Authors:
Open Access
- 1 February 2001
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 56 (2) , M113-M119
Abstract
Background. The prevalence of erectile dysfunction (ED) increases with advancing age, with a particularly high prevalence of ED in elderly patients with diabetes. In the United States it is estimated that approximately 45% of men aged 65 to 69 years have moderate or complete ED. The efficacy and safety of oral sildenafil (VIAGRA®) for treating ED in elderly men (aged ≥65 years or older) were assessed. Methods. We analyzed data obtained from five double-blind, placebo-controlled studies of the efficacy and tolerability of oral sildenafil taken as required (but not more than once daily) over a 12-week to 6-month period. Two subgroups were evaluated: (i) elderly patients with ED of broad-spectrum etiology (n = 411), and (ii) elderly patients with ED and diabetes (n = 71). Efficacy was assessed using a global efficacy question, questions 3 and 4 of the International Index of Erectile Function (IIEF), and the five sexual function domains of the IIEF. Results. All efficacy assessments indicated that sildenafil significantly improved erectile function both in elderly patients with ED of broad-spectrum etiology and in elderly patients with ED and diabetes. The most common adverse events were mild-to-moderate headache, flushing, and dyspepsia. The rates of discontinuation due to adverse events were low and were comparable to the rates with placebo. Conclusions. Sildenafil is an efficacious and well-tolerated treatment for ED in elderly men.Keywords
This publication has 29 references indexed in Scilit:
- COMPARISON OF LONG-TERM OUTCOMES OF PENILE PROSTHESES AND INTRACAVERNOSAL INJECTION THERAPYJournal of Urology, 1998
- Comparative Results of Goal Oriented Therapy for Erectile DysfunctionJournal of Urology, 1997
- Quality of Life Effects of Alprostadil Therapy for Erectile DysfunctionJournal of Urology, 1997
- Predictors of Success and Risk Factors for Attrition in the Use of Intracavernous InjectionJournal of Urology, 1997
- Treatment of Men with Erectile Dysfunction with Transurethral AlprostadilNew England Journal of Medicine, 1997
- Clinical Guidelines Panel on Erectile Dysfunction: Summary Report on the Treatment of Organic Erectile DysfunctionJournal of Urology, 1996
- Quality of Life in Patients Using Self-Administered Intracavernous Injections of Prostaglandin E1 for Erectile DysfunctionJournal of Urology, 1996
- The effect of age, ethnicity and geographical location on impotence and quality of lifeBritish Journal of Urology, 1995
- Drugs and Impaired Male Sexual FunctionDrugs, 1979
- DIABETIC NEUROPATHYMedicine, 1945